Regular articleImmunopathology and infectious diseasesSignificantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
Immunopathology and infectious diseases
Under an Elsevier user license
open archive
Cited by (0)
Supported by the Fondren Foundation (J.M.M.), Houston Methodist Hospital (J.M.M.), and the Houston Methodist Research Institute (J.M.M.).
Disclosures: E.S. is the local principal investigator for a clinical trial sponsored by Regeneron, assessing an investigational therapy for COVID-19.
© 2021 American Society for Investigative Pathology. Published by Elsevier Inc.